Jeong-Eun Park,1,2,* Woo Cheol Kim,3,* Sung Kyun Kim,4,5,* Yeji Ahn,1,2 Sun Mok Ha,1,2 Gahee Kim,3 Seonmin Choi,3 Wan Su Yun,3 Tae Hoon Kong,1,2 Su Hoon Lee,1,2 Dong Jun Park,1,2 Jin Sil Choi,1,2 Jaehong Key,3 Young Joon Seo1,2 1Department of Otorhinolaryngology, Yonsei University Wonju College of Medicine, Wonju, 26426, South Korea; 2Research Institute of Hearing Enhancement, Yonsei University Wonju College of Medicine, Wonju, 26426, South Korea; 3Department of Biomedical Engineering, Yonsei University, Wonju, South Korea; 4Department of Otorhinolaryngology Head and Neck Surgery, Hallym University College of Medicine, Dongtan Sacred Heart Hospital, Hwaseong, South Korea; 5Laboratory of Brain & Cognitive Science for Convergence Medicine, Hallym University College of Medicine, Anyang, South Korea*These authors contributed equally to this workCorrespondence: Young Joon Seo, Department of Otorhinolaryngology, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju, 26426, South Korea, Tel +82 33 741 0644, Email okas2000@hanmail.net Jaehong Key, Department of Biomedical Engineering, Yonsei University, 1 Yonseidae-gil, Wonju, Gangwon-do, 26493, South Korea, Tel +82 33 760 2857, Email jkey@yonsei.ac.krBackground: Ototoxicity currently has no available treatment other than medication withdrawal as soon as toxicity is suspected. The human inner ear organs have little potential for regeneration; thus, ototoxicity-induced hair cell injury is deemed permanent. Dexamethasone (Dexa) is a synthetic steroid analog that has significant potential for otoprotection in the treatment of various inner ear diseases; however, its low absorption into the inner ear prevents significant recovery of function. Nanoparticles facilitate targeted drug delivery, stabilize drug release, and increase half-life of the drug.Methods: This study aimed to develop poly(lactic-co-glycolic acid) (PLGA) nanoparticles loaded superparamagnetic iron oxide nanoparticles (SPIONs) and Dexa (PSD-NPs) to control localized drug delivery by magnetic attraction in the treatment of ototoxicity-induced hearing loss. PSD-NPs and without SPIONs (PD-NPs) were prepared using a nanoprecipitation method.Results: Using an inner ear simulating system, we confirmed that PSD-NPs has an otoprotective effect in organotypic culture that is enhanced by magnetic attraction. PSD-NPs delivered via intrabullar injection in a magnetic field penetrated the inner ear and prevented hearing loss progression to a greater degree than equivalent doses of Dexa or PSD-NPs alone (day 28: ototoxic: 80.0 ± 0.0 dB; Dexa 100: 60.0 ± 15.5 dB; PSD 100: 50.0 ± 8.2 dB; PSD 100 with magnet: 22.5 ± 5.0 dB; P < 0.05). The protective effects were confirmed in various in vivo and in vitro models of ototoxicity.Conclusion: Our findings suggest that SPIONs with Dexa and magnetic field application prevent the progression of ototoxicity-induced hearing loss through anti-apoptotic mechanisms in the inner ear.Graphical Abstract: Keywords: superparamagnetic iron oxide nanoparticles, ototoxicity, hearing loss, magnetic attraction, dexamethasone